Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
Titel:
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
Auteur:
Huselton, Eric Rettig, Michael P. Campbell, Kirsten Cashen, Amanda F. DiPersio, John F. Gao, Feng Jacoby, Meagan A. Pusic, Iskra Romee, Rizwan Schroeder, Mark A. Uy, Geoffrey L. Marcus, Stephen Westervelt, Peter